Correlation Between Bluebird Bio and Intellia Therapeutics
Can any of the company-specific risk be diversified away by investing in both Bluebird Bio and Intellia Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bluebird Bio and Intellia Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Bluebird bio and Intellia Therapeutics, you can compare the effects of market volatilities on Bluebird Bio and Intellia Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bluebird Bio with a short position of Intellia Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bluebird Bio and Intellia Therapeutics.
Diversification Opportunities for Bluebird Bio and Intellia Therapeutics
0.17 | Correlation Coefficient |
Average diversification
The 3 months correlation between Bluebird and Intellia is 0.17. Overlapping area represents the amount of risk that can be diversified away by holding Bluebird bio and Intellia Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Intellia Therapeutics and Bluebird Bio is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bluebird bio are associated (or correlated) with Intellia Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Intellia Therapeutics has no effect on the direction of Bluebird Bio i.e., Bluebird Bio and Intellia Therapeutics go up and down completely randomly.
Pair Corralation between Bluebird Bio and Intellia Therapeutics
Given the investment horizon of 90 days Bluebird bio is expected to generate 4.26 times more return on investment than Intellia Therapeutics. However, Bluebird Bio is 4.26 times more volatile than Intellia Therapeutics. It trades about 0.06 of its potential returns per unit of risk. Intellia Therapeutics is currently generating about -0.2 per unit of risk. If you would invest 834.00 in Bluebird bio on November 1, 2024 and sell it today you would lose (43.00) from holding Bluebird bio or give up 5.16% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Bluebird bio vs. Intellia Therapeutics
Performance |
| Timeline |
| Bluebird bio |
| Intellia Therapeutics |
Bluebird Bio and Intellia Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Bluebird Bio and Intellia Therapeutics
The main advantage of trading using opposite Bluebird Bio and Intellia Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bluebird Bio position performs unexpectedly, Intellia Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Intellia Therapeutics will offset losses from the drop in Intellia Therapeutics' long position.| Bluebird Bio vs. Mersana Therapeutics | Bluebird Bio vs. Zentalis Pharmaceuticals Llc | Bluebird Bio vs. Y mAbs Therapeutics | Bluebird Bio vs. Travere Therapeutics |
| Intellia Therapeutics vs. Editas Medicine | Intellia Therapeutics vs. Caribou Biosciences | Intellia Therapeutics vs. Crispr Therapeutics AG | Intellia Therapeutics vs. Verve Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.
Other Complementary Tools
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal |